A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications
Author(s)
Type
Journal Article
Date Issued
2023-04-18
Date Acceptance
2023-04-03
Citation
Blood Cancer Journal, 2023, 13 (1)
ISSN
2044-5385
Publisher
Nature Publishing Group
Journal / Book Title
Blood Cancer Journal
Volume
13
Issue
1
Copyright Statement
© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/37072385
PII: 10.1038/s41408-023-00827-5
Subjects
Humans
Lymphoma, Large B-Cell, Diffuse
Prognosis
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-myc
Retrospective Studies
World Health Organization
Publication Status
Published
Coverage Spatial
United States
Article Number
ARTN 54